Allergic Conjunctivitis Market
According to Intent Market Research, the Allergic Conjunctivitis Market is expected to grow from USD 2.6 Billion in 2024-e at a CAGR of 11.1% to touch USD 5.0 Billion by 2030. The Allergic Conjunctivitis Market is dominated by key players such as, Novartis International AG, Bausch & Lomb Incorporated, Johnson & Johnson, Allergan plc, Pfizer Inc., and Santen Pharmaceutical Co., Ltd.